Compare AQMS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AQMS | HBIO |
|---|---|---|
| Founded | 2014 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 22.1M |
| IPO Year | 2015 | 2000 |
| Metric | AQMS | HBIO |
|---|---|---|
| Price | $5.06 | $0.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $2.50 |
| AVG Volume (30 Days) | 82.2K | ★ 415.6K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,100,000.00 | ★ $116,176,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $550.00 | $7.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.34 | $0.28 |
| 52 Week High | $39.37 | $0.95 |
| Indicator | AQMS | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 51.38 |
| Support Level | $4.62 | $0.41 |
| Resistance Level | $8.37 | $0.64 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 72.29 | 60.25 |
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.